Lipid membranes and β-amyloid: A harmful connection

Current Protein and Peptide Science

Volumn 11, Issue 5, 2010, Pages 319-325

  Eckert, G P ^a   Wood, W G ^b   Muller W E ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer; Amyloid; Calcium; Cholesterol; Diphenylhexatriene; Ganglioside; Membrane; Membrane fluidity; Pyrene

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; AMYLOID BETA PROTEIN; CALCIUM; CHOLESTEROL; GANGLIOSIDE; GANGLIOSIDE GM1; PHOSPHOLIPID; PYRENE; SECRETASE;

ALZHEIMER DISEASE; ARTICLE; ARTIFICIAL MEMBRANE; CALCIUM SIGNALING; CELL MEMBRANE; ENZYME ACTIVITY; LIPID MEMBRANE; MEMBRANE FLUIDITY; PROTEIN INTERACTION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CALCIUM SIGNALING; CELL MEMBRANE; CHOLESTEROL; G(M1) GANGLIOSIDE; HUMANS; LIPID BILAYERS;

EID: 77957994639     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920310791330668     Document Type: Article

References (103)

1. Haass, C.; Selkoe, D.J. Soluble protein oligomers in neurodegen- eration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol., 2007, 8, 101-112.
2. Selkoe, D.J. The molecular pathology of Alzheimer's disease. Neuron, 1991, 6, 487-498.
3. Postina, R. A closer look at alpha-secretase. Curr. Alzheimer Res., 2008, 5, 179-186.
4. Deuss, M.; Reiss, K.; Hartmann, D. Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17. Curr. Alzheimer Res., 2008, 5, 187-201.
5. Kögel, D.; Schomburg, R.; Schurmann, T.; Reimertz, C.; König, H.G.; Poppe, M.; Eckert, A.; Müller, W.E.; Prehn, J.H. The amy- loid precursor protein protects PC12 cells against endoplasmic re- ticulum stress-induced apoptosis. J. Neurochem., 2003, 87, 248-256.
6. Vassar, R.; Bennett, B.D.; Babu-Khan, S.; Kahn, S.; Mendiaz, E.A.; Denis, P.; Teplow, D.B.; Ross, S.; Amarante, P.; Loeloff, R.; Luo, Y.; Fisher, S.; Fuller, J.; Edenson, S.; Lile, J.; Jarosinski, M.A.; Biere, A.L.; Curran, E.; Burgess, T.; Louis, J.C.; Collins, F.; Treanor, J.; Rogers, G.; Citron, M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane as- partic protease BACE. Science, 1999, 286, 735-741.
7. Maltese, W.A.; Wilson, S.; Tan, Y.; Suomensaari, S.; Sinha, S.; Barbour, R.; McConlogue, L. Retention of the Alzheimer's amyloid precursor fragment C99 in the endoplasmic reticulum prevents formation of amyloid beta-peptide. J. Biol. Chem., 2001, 276, 20267-79.
8. Kim, S.H.; Leem, J.Y.; Lah, J.J.; Slunt, H.H.; Levey, A.I.; Thinakaran, G.; Sisodia, S.S. Multiple effects of aspartate mutant presenilin 1 on the processing and trafficking of amyloid precursor protein. J. Biol. Chem., 2001, 276, 43343-43350.
9. Cuello, A.C. Intracellular and extracellular Abeta, a tale of two neuropathologies. Brain Pathol., 2005, 15, 66-71.
10. Golde, T.E.; Dickson, D.; Hutton, M. Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease. Curr. Alzheimer Res., 2006, 3, 421-430.
11. Caughey, B.; Lansbury, P.T. Protofibrils, pores, fibrils, and neu- rodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci., 2003, 26, 267-298.
12. Pike, C.J.; Burdick, D.; Walencewicz, A.J.; Glabe, C.G.; Cotman, C.W. Neurodegeneration induced by beta-amyloid peptides in vi- tro: the role of peptide assembly state. J. Neurosci., 1993, 13, 1676-1687.
13. Yankner, B.A.; Duffy, L.K.; Kirschner, D.A. Neurotrophic and neurotoxic effects of amyloid - beta protein: Reversal by tachykinin neuropeptides. Science, 1990, 250, 279-282.
14. Kawahara, M.; Kuroda, Y. Molecular mechanism of neurodegen- eration induced by Alzheimer's beta-amyloid protein: channel for- mation and disruption of calcium homeostasis. Brain Res. Bull., 2000, 53, 389-397.
15. Small, D.H.; McLean, C.A. Alzheimer's disease and the amyloid beta protein: What is the role of amyloid? J. Neurochem., 1999, 73, 443-449.
16. Hartmann, H.; Eckert, A.; Müller, W.E. Beta-Amyloid protein amplifies calcium signalling in central neurons from the adult mouse. Biochem. Biophys. Res. Commun., 1993, 194, 1216-1220.
17. Butterfield, D.A.; Howard, B.; Yatin, S.; Koppal, T.; Drake, J.; Hensley, K.; Aksenov, M.; Aksenova, M.; Subramaniam, R.; Varadarajan, S.; Harris-White, M.E.; Pedigo, N.W.; Carney, J.M. Elevated oxidative stress in models of normal brain aging and Alzheimer's disease. Life Sci., 1999, 65, 1883-1892.
18. Keller, J.N.; Mark, R.J.; Bruce, A.J.; Blanc, E.; Rothstein, J.D.; Uchida, K.; Waeg, G.; Mattson, M. P. 4-hydroxynonenal, an alde- hydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience, 1997, 80, 685-696.
19. Mattson, M.P.; Tomaselli, K.J.; Rydel, R.E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res., 1993, 621, 35-49.
20. McLaurin, J.; Chakrabartty, A. Membrane disruption by Alzheimer beta-amyloid peptides mediated through specific finding to either phospholipids or gangliosides - Implications for neurotoxicity. J. Biol. Chem., 1996, 271, 26482-26489.
21. Chauhan, A.; Chauhan, V.P.S.; Brockerhoff, H.; Wisniewski, H.M.; Corain, B.; Iqbal, K.; Nicolini, M.; Winblad, B.; Wisniewski, H.; Zatta, P. In Alzheimer's Disease: Advances in Clinical and Basic Research; John Wiley & Sons LTD: New York, 1993, pp. 431-439.
22. Mattson, M.P. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev., 1997, 77, 1081-1132.
23. (2+)-channel hypothesis for neuronal death in Alzheimer disease. Mol. Cell Biochem., 1994, 140, 119-125.
24. Wood, W.G.; Eckert, G.P.; Igbavboa, U.; Müller, W.E. Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease. Biochimica. Biophysica. Acta-Biomembr., 2003, 1610, 281-290.
25. Yeagle, P.L. Lipid regulation of cell membrane structure and function. FASEB J., 1989, 3, 1833-1842.
26. Lakowicz, J.R. In Principles of Fluorescence Spectroscopy; Plenum Press: New York, 1983; Vol. 1, pp. 112-151.
27. Mason, R.P.; Estermyer, J.D.; Kelly, J.F.; Mason, P.E. Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis. Biochem. Biophys. Res. Commun., 1996, 222, 78-82.
28. Fletcher, T.G.; Keire, D.A. The interaction of beta-amyloid protein fragment (12-28) with lipid environments. Protein Sci., 1997, 6, 666-675.
29. McLaurin, J.; Chakrabartty, A. Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes. Eur. J. Biochem., 1997, 245, 355-363.
30. Lin, M.S.; Chen, X.B.; Wang, S.S.; Chang, Y.; Chen, W.Y. Dy- namic fluorescence imaging analysis to investigate the cholesterol recruitment in lipid monolayer during the interaction between beta- amyloid (1-40) and lipid monolayers. Colloids Surf B Biointer- faces, 2009, 74, 59-66.
31. Widenbrant, M.J.; Rajadas, J.; Sutardja, C.; Fuller, G.G. Lipid- induced beta-amyloid peptide assemblage fragmentation. Biophys. J., 2006, 91, 4071-80.
32. Kaiser, R.D.; London, E. Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluo- rescence quenching analyses of membrane depth. Biochemistry, 1998, 37, 8180-8190.
33. Terzi, E.; Holzemann, G.; Seelig, J. Interaction of Alzheimer beta- amyloid peptide(1-40) with lipid membranes. Biochemistry, 1997, 36, 14845-14852.
34. Wong, P.T.; Schauerte, J.A.; Wisser, K.C.; Ding, H.; Lee, E.L.; Steel, D.G.; Gafni, A. Amyloid-beta membrane binding and per- meabilization are distinct processes influenced separately by mem- brane charge and fluidity. J. Mol. Biol., 2009, 386, 81-96.
35. Yamaguchi, H.; Maat-Schieman, M.L.; van Duinen, S.G.; Prins, F.A.; Neeskens, P.; Natte, R.; Roos, R.A. Amyloid beta protein (Abeta) starts to deposit as plasma membrane-bound form in dif- fuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease and nondemented aged subjects. J. Neuropathol. Exp. Neurol., 2000, 59, 723-732.
36. Torp, R.; Head, E.; Cotman, C. W. Ultrastructural analyses of beta- amyloid in the aged dog brain: neuronal beta-amyloid is localized to the plasma membrane. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2000, 24, 801-810.
37. Oshima, N.; Morishima-Kawashima, M.; Yamaguchi, H. Yoshimura, M.; Sugihara, S.; Khan, K.; Games, D.; Schenk, D.; Ihara, Y. Accumulation of amyloid beta-protein in the low-density membrane domain accurately reflects the extent of beta-amyloid deposition in the brain. Am. J. Pathol., 2001, 158, 2209-2218.
38. Hayashi, H.; Mizuno, T.; Michikawa, M.; Haass, C.; Yanagisawa, K. Amyloid precursor protein in unique cholesterol-rich microdo- mains different from caveolae-like domains. Biochim. Biophys. Acta, 2000, 1483, 81-90.
39. Mason, R.P.; Jacob, R.F.; Walter, M.F.; Mason, P.E.; Avdulov, N.A.; Chochina, S.V.; Igbavboa, U.; Wood, W.G. Distribution and fluidizing action of soluble and aggregated amyloid beta - peptide in rat synaptic plasma membranes. J. Biol. Chem., 1999, 274, 18801-18807.
40. Valincius, G.; Heinrich, F.; Budvytyte, R.; Vanderah, D.J.; McGillivray, D.J.; Sokolov, Y.; Hall, J.E.; Losche, M. Soluble amyloid beta-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity. Biophys. J., 2008, 95, 4845-4861.
41. Hartmann, H.; Eckert, A.; Müller, W.E. Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity. Biochem. Biophys. Res. Commun., 1994, 200, 1185-1192.
42. Müller, W.E.; Koch, S.; Eckert, A.; Hartmann, H. Scheuer, K. Beta-Amyloid Peptide Decreases Membrane Fluidity. Brain Res., 1995, 674, 133-136.
43. Müller, W.E.; Eckert, G.P.; Scheuer, K.; Cairns, N.J.; Maras, A.; Gattaz, W.F. Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43. Amyloid-J. Protein Fold. Disord., 1998, 5, 10-15.
44. Kirsch, C.; Eckert, G.P.; Müller, W.E. Cholesterol attenuates the membrane perturbing properties of beta-amyloid peptides. Amyloid, 2002, 9, 149-159.
45. Eckert, G.P.; Wood, W.G.; Müller, W.E. Effects of aging and beta- amyloid on the properties of brain synaptic and mitochondrial membranes. J. Neural. Transm., 2001, 108, 1051-1064.
46. Eckert, G.P.; Cairns, N.J.; Maras, A.; Gattaz, W.F.; Müller, W.E. Cholesterol modulates the membrane-disordering effects of beta- amyloid peptides in the hippocampus: specific changes in Alz-heimer's disease. Dement. Geriatr. Cogn. Disord., 2000, 11, 181-186.
47. Yip, C.M.; McLaurin, J. Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys. J., 2001, 80, 1359-1371.
48. Mantha, A.K.; Moorthy, K.; Cowsik, S.M.; Baquer, N.Z. Mem- brane associated functions of neurokinin B (NKB) on Abeta (25- 35) induced toxicity in aging rat brain synaptosomes. Biogerontology, 2006, 7, 19-33.
49. Peters, I.; Igbavboa, U.; Schutt, T.; Haidari, S.; Hartig, U.; Rosello, X.; Bottner, S.; Copanaki, E.; Deller, T.; Kogel, D.; Wood, W.G.; Müller, W.E.; Eckert, G.P. The interaction of beta-amyloid protein with cellular membranes stimulates its own production. Biochim. Biophys. Acta, 2009, 1788, 964-72.
50. Pike, C.J.; Walencewicz, A.J.; Glabe, C.G.; Cotman, C.W. Aggre- gation-related toxicity of synthetic beta-amyloid protein in hippo- campal cultures. Eur. J. Pharmacol., 1991, 207, 367-368.
51. Chochina, S.V.; Avdulov, N.A.; Igbavboa, U.; Cleary, J.P.; O'Hare, E.O.; Wood, W.G. Amyloid beta-peptide(1-40) increases neuronal membrane fluidity. Role of cholesterol and brain region. J. Lipid Res., 2001, 42, 1292-1297.
52. Avdulov, N.A.; Chochina, S.V.; Igbavboa, U.; O'Hare, E.O.; Schroeder, F.; Cleary, J.P.; Wood, W.G. Amyloid beta-peptides in- crease annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes. J. Neurochem., 1997, 68, 2086-2091.
53. Waschuk, S.; Elton, E.A.; Darabie, A.A.; Fraser, P.E.; McLaurin, J. Cellular membrane composition defines A -lipid interactions. J. Biol. Chem., 2001, 276(36), 33561-33568.
54. Wood, W.G.; Eckert, G.P.; Igbavboa, U.; Müller, W.E. Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease. Biochim. Biophys. Acta, 2003, 1610, 281-290.
55. Mulders, F.; van Langen, H.; Van Ginkel, G.; Levine, Y.K. The static and dynamic behaviour of fluorescent probe molecules in lipid bilayers. Biochim. Biophys. Acta, 1986, 859, 209-218.
56. Wood, W.G.; Igbabvoa, U.; Eckert, G.P.; Müller, W.E. In Neural Membranes and Transport, Lajtha; Reith, A.; Marten, E.A.; Eds.; Plenum Press: New York, 2007; Vol. XIV, p. 513.
57. Eckert, G.P.; Kirsch, C.; Leutz, S.; Wood, W.G.; Müller, W.E. Cholesterol modulates amyloid beta-peptide's membrane interactions. Pharmacopsychiatry, 2003, 36(Suppl 2), S136-S143.
58. Wood, W.G.; Schroeder, F.; Igbavboa, U.; Avdulov, N.A.; Chochina, S.V. Brain membrane cholesterol domains, aging and amyloid beta-peptides. Neurobiol. Aging, 2002, 23, 685.
59. Palacino, J.J.; Murphy, M.P.; Murayama, O.; Iwasaki, K.; Fujiwara, M.; Takashima, A.; Golde, T.E.; Wolozin, B. Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen syn- thase kinase-3-independent fashion. J. Biol. Chem., 2001, 276, 38563-38569.
60. Kirsch, C.; Eckert, G.P.; Müller, W.E. Statins affect cholesterol micro-domains in brain plasma membranes. Biochem. Pharmacol., 2003, 65, 843-856.
61. Igbavboa, U.; Avdulov, N.A.; Schroeder, F.; Wood, W.G. Increas- ing age alters transbilayer fluidity and cholesterol asymetry in syn- aptic plasma membrane of mice. J. Neurochem., 1996, 66, 1717-1725.
62. Wood, W.G.; Igbavboa, U. Cholesterol trafficking and amyloid beta peptides. Pharmacopsychiatry, 2003, 36(Suppl 2), S144-S148.
63. Wood, W.G.; Schroeder, F.; Avdulov, N.A.; Chochina, S.V.; Igbavboa, U. Recent advances in brain cholesterol dynamics: trans- port, domains, and Alzheimer's disease. Lipids, 1999, 34, 225-234.
64. Simons, K.; Ikonen, E. Functional rafts in cell membranes. Nature, 1997, 387, 569-572.
65. Eckert, G.P.; Igbavboa, U.; Müller, W.E.; Wood, W.G. Lipid rafts of purified mouse brain synaptosomes prepared with or without de- tergent reveal different lipid and protein domains. Brain Res., 2003, 962, 144-150.
66. Eckert, G.P. Manipulation of lipid rafts in neuronal cells. Open Biol. J., 2010, 3, 32-38.
67. Brown, D.A.; London, E. Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol., 1998, 164, 103-114.
68. Simons, K.; Ikonen, E. How cells handle cholesterol. Science, 2000, 290, 1721-1726.
69. Simons, K.; Toomre, D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol., 2000, 1, 31-39.
70. Eckert, G.P.; Wood, W.G.; Müller, W.E. Cholesterol lowering drugs and Alzheimer's disease. Future Lipidol., 2007, 2, 423-432.
71. Arispe, N.; Doh, M. Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease A·P (1-40) and (1-42) peptides. FASEB J., 2002, 16, 1526-1536.
72. Mattson, M.P.; Barger, S.W.; Cheng, B.; Lieberburg, I.; Smith-Swintosky, V.L.; Rydel, R.E. beta-Amyloid precursor protein me-tabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. Trends Neurosci., 1993, 16, 409-414.
73. Dante, S.; Hauss, T.; Dencher, N.A. Cholesterol inhibits the inser- tion of the Alzheimer's peptide Abeta(25-35) in lipid bilayers. Eur. Biophys. J, 2006, 35, 523-531.
74. Mina, E.W.; Lasagna-Reeves, C.; Glabe, C.G.; Kayed, R. Polox- amer 188 copolymer membrane sealant rescues toxicity of amyloid oligomers in vitro. J. Mol. Biol., 2009, 391, 577-585.
75. Yanagisawa, K. Role of gangliosides in Alzheimer's disease. Bio- chim. Biophys. Acta, 2007, 1768, 1943-1951.
76. Wakabayashi, M.; Okada, T.; Kozutsumi, Y.; Matsuzaki, K. GM1 ganglioside-mediated accumulation of amyloid beta-protein on cell membranes. Biochem. Biophys. Res. Commun., 2005, 328, 1019-1023.
77. Pei, B.; Chen, J.W. More ordered, convex ganglioside-enriched membrane domains: the effects of GM1 on sphingomyelin bilayers containing a low level of cholesterol. J. Biochem.(Tokyo), 2003, 134, 575-581
78. Nishio, M.; Fukumoto, S.; Furukawa, K.; Ichimura, A.; Miyazaki, H.; Kusunoki, S.; Urano, T. Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells. J. Biol. Chem., 2004, 279, 33368-33378.
79. Forstner, M.B.; Yee, C.K.; Parikh, A.N.; Groves, J.T. Lipid lateral mobility and membrane phase structure modulation by protein binding. J. Am. Chem. Soc., 2006, 128, 15221-15227.
80. Tamboli, I.Y.; Prager, K.; Barth, E.; Heneka, M.; Sandhoff, K.; Walter, J. Inhibition of glycosphingolipid biosynthesis reduces se- cretion of the {beta}-amyloid precursor protein and amyloid {beta}-peptide. J. Biol. Chem., 2005, 280, 28110-28117.
81. Zha, Q.; Ruan, Y.; Hartmann, T.; Beyreuther, K.; Zhang, D. GM1 ganglioside regulates the proteolysis of amyloid precursor protein. Mol. Psychiatry, 2004, 9, 946-952.
82. Tashima, Y.; Oe, R.; Lee, S.; Sugihara, G.; Chambers, E.J.; Takahashi, M.; Yamada, T. The effect of cholesterol and monosia-loganglioside (GM1) on the release and aggregation of amyloid beta-peptide from liposomes prepared from brain membrane-like lipids. J. Biol. Chem., 2004, 279, 17587-17595.
83. Burger, K.; Gimpl, G.; Fahrenholz, F. Regulation of receptor function by cholesterol. Cell Mol. Life Sci., 2000, 57, 1577-1592.
84. McDonald, D.R.; Brunden, K.R.; Landreth, G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci., 1997, 17, 2284-2294.
85. Shimohama, S.; Matsushima, H. Signal transduction mechanisms in Alzheimer disease. Alzheimer. Dis. Assoc. Disord., 1995, 9 (Suppl 2), 15-22.
86. 2+ signalling in fully differentiated brain cells of adult mice. Amyloid-Int. J. Exp. Clin. Invest., 1996, 3, 234-241.
87. Mattson, M.P.; Chan, S.L. Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium, 2003, 34, 385-397.
88. Haughey, N.J.; Mattson, M.P. Alzheimer's amyloid beta-peptide enhances ATP/gap junction-mediated calcium-wave propagation in astrocytes. Neuromol. Med., 2003, 3, 173-180.
89. Hartmann, H.; Eckert, A.; Forstl, H.; Müller, W.E. Similar agerelated changes of free intracellular calcium in lymphocytes and central neurons: effects of Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci., 1994, 243, 218-223.
90. Arispe, N.; Pollard, H.B.; Rojas, E. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P- (1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. USA, 1993, 90, 10573-10577.
91. Ye, C.P.; Selkoe, D.J.; Hartley, D.M. Protofibrils of amyloid betaprotein inhibit specific K+ currents in neocortical cultures. Neurobiol. Dis., 2003, 13, 177-190.
92. Soomets, U.; Mahlapuu, R.; Tehranian, R.; Jarvet, J.; Karelson, E.; Zilmer, M.; Iverfeldt, K.; Zorko, M.; Graslund, A.; Langel, U. Regulation of GTPase and adenylate cyclase activity by amyloid beta- peptide and its fragments in rat brain tissue. Brain Res., 1999, 850, 179-188.
93. Cowburn, R.F.; O'Neill, C.; Bonkale, W.L.; Ohm, T.G.; Fastbom, J. Receptor-G-protein signalling in Alzheimer's disease. Biochem. Soc. Symp., 2001, 163-175.
94. Olariu, A.; Yamada, K.; Mamiya, T.; Hefco, V.; Nabeshima, T. Memory impairment induced by chronic intracerebroventricular infusion of beta-amyloid (1-40) involves downregulation of protein kinase C. Brain Res., 2002, 957, 278-286.
95. Garrido, J.L.; Godoy, J.A.; Alvarez, A.; Bronfman, M.; Inestrosa, N.C. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. FASEB J., 2002, 16, 1982-1984.
96. Zhou, S.; Zhou, H.; Walian, P.J.; Jap, B.K. Regulation of gammasecretase activity in Alzheimer's disease. Biochemistry, 2007, 46, 2553-2563.
97. Bodovitz, S.; Klein, W.L. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J Biol. Chem., 1996, 271, 4436-4440.
98. Kojro, E.; Gimpl, G.; Lammich, S.; Marz, W.; Fahrenholz, F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. USA, 2001, 98, 5815-5820.
99. Gamerdinger, M.; Clement, A.B.; Behl, C. Effects of sulindac sulfide on the membrane architecture and the activity of gammasecretase. Neuropharmacology, 2008, 54, 998-1005.
100. von Arnim, C.A.; von Einem, B.; Weber, P.; Wagner, M.; Schwanzar, D.; Spoelgen, R.; Strauss, W.L.; Schneckenburger, H. Impact of cholesterol level upon APP and BACE proximity and APP cleavage. Biochem. Biophys. Res. Commun., 2008, 370, 207-12.
101. Suzuki, H.; Park, S.J.; Tamura, M.; Ando, S. Effect of the longterm feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet. Mech. Ageing Dev., 1998, 101, 119-128.
102. Green, K.N.; Martinez-Coria, H.; Khashwji, H.; Hall, E.B.; Yurko-Mauro, K.A.; Ellis, L.; LaFerla, F.M. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci., 2007, 27, 4385-4395.
103. Oksman, M.; Iivonen, H.; Hogyes, E.; Amtul, Z.; Penke, B.; Leenders, I.; Broersen, L.; Lutjohann, D.; Hartmann, T.; Tanila, H. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol. Dis., 2006, 23, 563-572.